Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

inositol nicotinate, mefruside, reserpine drug combination MeSH Supplementary Concept Data 2025


MeSH Supplementary
inositol nicotinate, mefruside, reserpine drug combination
Unique ID
C000242
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000242
Entry Term(s)
Bay Mc 4540
Bendigon
inositol nicotinate - mefruside - reserpine
Pharm Action
Antihypertensive Agents
Registry Numbers
0
Previous Indexing
*DIURETICS, SULFAMYL (75-76)
*SULFONAMIDES (72-75)
Heading Mapped to
Drug Combinations
*Mefruside
*Nicotinic Acids
*Reserpine
Frequency
3
Note
contains reserpine, mefruside & inositolnicotinate
Source
Med Klin 70(3):102;1975
Med Welt 37:1617;1970
Date of Entry
1972/01/01
Revision Date
2011/08/05
inositol nicotinate, mefruside, reserpine drug combination Preferred
Bay Mc 4540 Narrower
Bendigon Narrower
page delivered in 0.005s